FONAR Corporation delivered a modest top-line performance in QQ2 2025, with revenue of $24.95 million and net income of $1.964 million, translating to earnings per share of $0.29. While revenue declined slightly year-over-year (-1.72%) and quarter-over-quarter (-0.04%), the company maintained positive profitability, generating an EBITDA of $3.175 million and an operating margin of 9.76%. The quarterly results reflect a conservative operating profile consistent with a small-cap medical devices player focused on MRI technology and related services. Net cash position remains robust, with cash and equivalents of $53.58 million and a net cash balance of approximately ($14.81) million, supporting balance sheet resilience as the company contends with a high receivable balance and extended working capital cycles.